Treating Pulmonary Embolism Today

Slides:



Advertisements
Similar presentations
Addressing the Challenges in Primary and Secondary Stroke Prevention
Advertisements

Covering the Bases in Cardioversion
CHA2DS2-VASc Scoring System General AF Treatment Guidance.
Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors.
Silent No More:.
Burden of Atrial Fibrillation The Percentage of Strokes Attributable to AF Increases With Age.
NOACs for Cancer-Associated Thrombosis:
Anticoagulants in Interventional Cardiology:
NOACs In Long-term VTE Treatment: A State Of The Art Review
Updates in Anticoagulation: What Did We Learn From ESC 2017?
Long-Term Treatment of VTE: Case Studies
US Guidelines US Guidelines Low-risk Patients.
NOACs, AF, and PCI: What Do the Latest Data Suggest?
Barriers to Oral Anticoagulant Use for Stroke Prevention in AF
The ABCs of AF.
Access to NOAC Therapy:
NOACs in Clinical Practice: Are They All the Same?
Appropriate Stroke Prevention Strategies in Atrial Fibrillation
Introduction ESC Annual Meeting in Review: NOACs and NVAF: Real-World Data, Guidelines, and More.
A New Era for NOACs:.
Anticoagulation Highlights From the American Heart Association Meeting 2017.
Clinical Presentations of VTEa,b NOACs VTE Acute Treatment Trials.
REVERSAL AGENTS FOR NOACS: Do WE NEED THEM in THE EP LAB?
Oral Anticoagulants in AFa,b A Brief History.
Surveying the Safety of NOACs in the Real World
A Case Challenge: Anticoagulant Choices for Acute PE
NOAC Use in AF: REAL-WORLD Studies WITH REAL RESULTS
Revealing Characteristics of Patients at High Risk for Developing Atrial Fibrillation.
The Essentials for Secondary Stroke Prevention
Assessing the Risk for Stroke in Patients With Atrial Fibrillation
Treatment Options to Consider
New Oral Anticoagulants and VTE Management
VTE Treatment Conventional Approach
Applying Real-World Evidence in Atrial Fibrillation Into Clinical Care:
Access to NOAC Therapy:
Antithrombotic Protection in CAD and HF
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Adherence in SPAF: Measures to Improve Care
What Anticoagulant Registries Are Revealing
Learning Objectives Classification of VTE Goals of VTE Treatment.
VTE in Cancer.
Oral Anticoagulation in AF
Extending Treatment for Thrombosis: What’s the Right Choice?
Practical Considerations to Extend Treatment for VTE
Atrial Fibrillation.
Extraordinary Cases of VTE Prevention in Patients With Cancer
Treating to Target in MS
Taking the "Cryptogenic" Out of Cryptogenic Stroke
Anticoagulation and Thrombosis Management
Identifying High-Risk AF Patients
Long-Term Treatment of VTE: Case Studies
Cancer-Associated Thrombosis
Improving Outcomes in AF: Do the NOACs Hold Their Promise In The Real World?
Updates in Anticoagulation: Key Sessions at ESC 2017
Managing Pulmonary Embolism Posthospital Discharge
NOAC Studies in VTE AF Studies Superior Outcomes.
Program Goals Background: Anticoagulation in Patients With VTE.
The ABCs of AF.
An Unmet Need.
Disease Burden of VTE Phases of VTE Treatment.
Taking the "Cryptogenic" Out of Cryptogenic Stroke
5 Good Minutes on Atrial Fibrillation-related Stroke
Selecting Treatment Approaches in Hemophilia
What is “AF Burden”?. What is “AF Burden”? AF Burden and Stroke Risk ASSERT Study.
At the Crossroads of Coagulation
VTE Treatment and Secondary Prevention VTE Treatment Trials Initial Dosing.
Uptitration of Medications in HF: Start Low but Aim High and Stay High
Top Tips in Evidence-Based Care for HFrEF
Extraordinary Cases in Stroke Prevention
What's New in NOACs in AF?.
Presentation transcript:

Treating Pulmonary Embolism Today

2019 ESC Guidelines for PE Acute Anticoagulant Treatment for PE

2019 ESC Guidelines for PE What Else Is New?

ISTH Guidance CAT

2019 ESC Guidelines for PE When NOACs Are Not Preferred

2019 ESC Guidelines for PE Early Discharge and Home Treatment

2019 ESC Guidelines for PE Risk Assessment

2019 ESC Guidelines for PE Can Anticoagulant Treatment Be Stopped?

Transient Risk Factors

Use of Clinical Scores

Extended Treatment Dosing

NOT the AF Dose!

2019 ESC Guidelines for PE Acute PE in Pregnancy

Follow-Up After PE

ESC Pocket Guidelines

Abbreviations

Abbreviations (cont)